-
Something wrong with this record ?
Natural Compounds Rosmarinic Acid and Carvacrol Counteract Aluminium-Induced Oxidative Stress
J. Baranauskaite, I. Sadauskiene, A. Liekis, A. Kasauskas, R. Lazauskas, U. Zlabiene, R. Masteikova, DM. Kopustinskiene, J. Bernatoniene
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 1997-01-01
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2009-03-01
Health & Medicine (ProQuest)
from 1997-01-01
- MeSH
- Antioxidants pharmacology MeSH
- Biological Products chemistry pharmacology MeSH
- Cinnamates chemistry pharmacology MeSH
- Cymenes chemistry pharmacology MeSH
- Depsides chemistry pharmacology MeSH
- Erythrocytes drug effects metabolism MeSH
- Aluminum adverse effects chemistry MeSH
- Liver drug effects metabolism MeSH
- Malondialdehyde metabolism MeSH
- Brain drug effects metabolism MeSH
- Mice MeSH
- Oxidative Stress drug effects MeSH
- Lipid Peroxidation drug effects MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Aluminum accumulation, glutathione (GSH) and malondialdehyde (MDA) concentrations as well as catalase (CAT) and superoxide dismutase (SOD) activities were determined in erythrocytes and brain and liver homogenates of BALB/c mice treated with Al3+ (7.5 mg/kg/day (0.15 LD50) as AlCl3 (37.08 mg/kg/day), whereas HCl (30.41 mg/kg/day) was used as Cl- control, the treatments were performed for 21 days, i.p., in the presence and absence of rosmarinic acid (0.2805 mg/kg/day (0.05 LD50), 21 days, i.g.) or carvacrol (0.0405 mg/kg/day (0.05 LD50), 21 days, i.g.). The treatment with AlCl3 increased GSH concentration in erythrocytes only slightly and had no effect on brain and liver homogenates. Rosmarinic acid and carvacrol strongly increased GSH concentration in erythrocytes but decreased it in brain and liver homogenates. However, AlCl3 treatment led to Al accumulation in mice blood, brain, and liver and induced oxidative stress, assessed based on MDA concentration in the brain and liver. Both rosmarinic acid and carvacrol were able to counteract the negative Al effect by decreasing its accumulation and protecting tissues from lipid peroxidation. AlCl3 treatment increased CAT activity in mice brain and liver homogenates, whereas the administration of either rosmarinic acid or carvacrol alone or in combination with AlCl3 had no significant effect on CAT activity. SOD activity remained unchanged after all the treatments in our study. We propose that natural herbal phenolic compounds rosmarinic acid and carvacrol could be used to protect brain and liver against aluminum induced oxidative stress leading to lipid peroxidation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012703
- 003
- CZ-PrNML
- 005
- 20210713153032.0
- 007
- ta
- 008
- 210420s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules25081807 $2 doi
- 035 __
- $a (PubMed)32326410
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Baranauskaite, Juste $u Department of Analytical and Toxicological Chemistry, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
- 245 10
- $a Natural Compounds Rosmarinic Acid and Carvacrol Counteract Aluminium-Induced Oxidative Stress / $c J. Baranauskaite, I. Sadauskiene, A. Liekis, A. Kasauskas, R. Lazauskas, U. Zlabiene, R. Masteikova, DM. Kopustinskiene, J. Bernatoniene
- 520 9_
- $a Aluminum accumulation, glutathione (GSH) and malondialdehyde (MDA) concentrations as well as catalase (CAT) and superoxide dismutase (SOD) activities were determined in erythrocytes and brain and liver homogenates of BALB/c mice treated with Al3+ (7.5 mg/kg/day (0.15 LD50) as AlCl3 (37.08 mg/kg/day), whereas HCl (30.41 mg/kg/day) was used as Cl- control, the treatments were performed for 21 days, i.p., in the presence and absence of rosmarinic acid (0.2805 mg/kg/day (0.05 LD50), 21 days, i.g.) or carvacrol (0.0405 mg/kg/day (0.05 LD50), 21 days, i.g.). The treatment with AlCl3 increased GSH concentration in erythrocytes only slightly and had no effect on brain and liver homogenates. Rosmarinic acid and carvacrol strongly increased GSH concentration in erythrocytes but decreased it in brain and liver homogenates. However, AlCl3 treatment led to Al accumulation in mice blood, brain, and liver and induced oxidative stress, assessed based on MDA concentration in the brain and liver. Both rosmarinic acid and carvacrol were able to counteract the negative Al effect by decreasing its accumulation and protecting tissues from lipid peroxidation. AlCl3 treatment increased CAT activity in mice brain and liver homogenates, whereas the administration of either rosmarinic acid or carvacrol alone or in combination with AlCl3 had no significant effect on CAT activity. SOD activity remained unchanged after all the treatments in our study. We propose that natural herbal phenolic compounds rosmarinic acid and carvacrol could be used to protect brain and liver against aluminum induced oxidative stress leading to lipid peroxidation.
- 650 _2
- $a hliník $x škodlivé účinky $x chemie $7 D000535
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a biologické přípravky $x chemie $x farmakologie $7 D001688
- 650 _2
- $a mozek $x účinky léků $x metabolismus $7 D001921
- 650 _2
- $a cinnamáty $x chemie $x farmakologie $7 D002934
- 650 _2
- $a cymeny $x chemie $x farmakologie $7 D000081007
- 650 _2
- $a depsidy $x chemie $x farmakologie $7 D053630
- 650 _2
- $a erytrocyty $x účinky léků $x metabolismus $7 D004912
- 650 _2
- $a peroxidace lipidů $x účinky léků $7 D015227
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a malondialdehyd $x metabolismus $7 D008315
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sadauskiene, Ilona $u Neuroscience Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania ; Department of Biochemistry, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
- 700 1_
- $a Liekis, Arunas $u Neuroscience Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
- 700 1_
- $a Kasauskas, Arturas $u Department of Biochemistry, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
- 700 1_
- $a Lazauskas, Robertas $u Institute of Physiology and Pharmacology, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
- 700 1_
- $a Zlabiene, Ugne $u Institute of Pharmaceutical Technologies, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
- 700 1_
- $a Masteikova, Ruta $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences Brno, 61242 Brno, Czech Republic
- 700 1_
- $a Kopustinskiene, Dalia M $u Institute of Pharmaceutical Technologies, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
- 700 1_
- $a Bernatoniene, Jurga $u Institute of Pharmaceutical Technologies, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania ; Department of Drug Technology and Social Pharmacy, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 25, č. 8 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32326410 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210713153029 $b ABA008
- 999 __
- $a ok $b bmc $g 1650964 $s 1133082
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 25 $c 8 $e 20200415 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20210420
